Clin2
NCT07704957Possibly a fitNot yet recruiting

Doxycycline after sex to prevent STIs in women

Chlamydia FemalesGonorrhea FemaleSyphilis FemaleAdherenceProphylaxisPrevention

Treatments studied

Part of Infections clinical trials.

This study tests whether taking a short course of the antibiotic doxycycline after sex can prevent bacterial STIs (like chlamydia, gonorrhea, and syphilis) in women at higher risk. It lasts one year and uses a smartphone app to track your health.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
519 people
Ages
18 years to 35 years
Study type
Interventional

Who can take part

  • You are female and between 18 and 35 years old.
  • You have had vaginal sex without a condom with men in the past.
  • You have either had a sexually transmitted infection (STI) in the past year or have had 2 or more sex partners in the past 6 months.
  • You are willing to stay sexually active for the next year and use a smartphone app for the study.
  • You are not pregnant, nursing, or trying to get pregnant, and you have no allergy to doxycycline or serious liver/kidney disease.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06743204Recruiting
Testing for sexually transmitted infections in women at risk for HIV

This study tests if combining sexually transmitted infection (STI) testing with HIV prevention medication (PrEP) helps control the HIV epidemic. It is for sexually active women aged 15-39 who live in Rakai and recently participated in a community health survey.

Kalisizo
NCT06738407Recruiting· Phase 4
Doxycycline to prevent STIs in high-risk people

This study tests whether taking a daily antibiotic (doxycycline) can prevent sexually transmitted infections in people at high risk. If you've had an STI recently and sometimes have sex without condoms, you might be able to join.

Los Angeles, California
NCT06007534Recruiting
Doxycycline for STI Prevention After Sex

This study looks at how a single 200 mg dose of doxycycline works in the body to prevent bacterial sexually transmitted infections (like chlamydia, gonorrhea, and syphilis) after a risky sexual encounter. It is for men who have sex with men and are already on PrEP or living with HIV.

Paris
NCT04762134Recruiting
Doxycycline to prevent future bacterial STIs in high-risk men

This trial tests whether taking doxycycline can lower the chance of getting bacterial sexually transmitted infections like syphilis, gonorrhea, and chlamydia. It is aimed at men who have had these infections recently and expect to keep having multiple male partners.

Calgary, Alberta
NCT07500415Recruiting
Doxycycline to prevent STIs in Rio de Janeiro

This trial tests whether taking the antibiotic doxycycline can prevent sexually transmitted infections (STIs) like chlamydia, gonorrhea, and syphilis in people at higher risk. If you are a man or transgender woman who has sex with men, are living with HIV or on PrEP, and have had an STI in the past year, you may be able to join.

Rio de Janeiro, Rio de Janeiro
NCT07397403Recruiting· Phase 4
Doxycycline to prevent STIs in men who have sex with men

This trial tests whether taking a single dose of doxycycline after sex can prevent common sexually transmitted infections (STIs) like gonorrhea, chlamydia, and syphilis in men who have sex with men (MSM) in Bangkok.

Sathorn, Bangkok

Hear when a new Adherence trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.